IL164048A0 - Primitive and proximal hepatic stemcells - Google Patents

Primitive and proximal hepatic stemcells

Info

Publication number
IL164048A0
IL164048A0 IL16404803A IL16404803A IL164048A0 IL 164048 A0 IL164048 A0 IL 164048A0 IL 16404803 A IL16404803 A IL 16404803A IL 16404803 A IL16404803 A IL 16404803A IL 164048 A0 IL164048 A0 IL 164048A0
Authority
IL
Israel
Prior art keywords
stemcells
primitive
proximal hepatic
hepatic
proximal
Prior art date
Application number
IL16404803A
Other languages
English (en)
Original Assignee
Univ North Carolina
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ North Carolina filed Critical Univ North Carolina
Publication of IL164048A0 publication Critical patent/IL164048A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/067—Hepatocytes
    • C12N5/0672—Stem cells; Progenitor cells; Precursor cells; Oval cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/20—Transition metals
    • C12N2500/24—Iron; Fe chelators; Transferrin
    • C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/36—Lipids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/11—Epidermal growth factor [EGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
    • G01N2333/70525—ICAM molecules, e.g. CD50, CD54, CD102
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70596—Molecules with a "CD"-designation not provided for elsewhere in G01N2333/705

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL16404803A 2002-03-15 2003-03-14 Primitive and proximal hepatic stemcells IL164048A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36536102P 2002-03-15 2002-03-15
PCT/US2003/007852 WO2003078588A2 (en) 2002-03-15 2003-03-14 Primitive and proximal hepatic stem cells

Publications (1)

Publication Number Publication Date
IL164048A0 true IL164048A0 (en) 2005-12-18

Family

ID=28042021

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16404803A IL164048A0 (en) 2002-03-15 2003-03-14 Primitive and proximal hepatic stemcells

Country Status (18)

Country Link
US (4) US7413897B2 (de)
EP (2) EP3023491A1 (de)
JP (2) JP4723811B2 (de)
KR (1) KR101119878B1 (de)
CN (3) CN104630129A (de)
AU (2) AU2003233399B2 (de)
CA (1) CA2479510C (de)
CY (1) CY1118167T1 (de)
DK (1) DK1490480T3 (de)
ES (1) ES2569951T3 (de)
HK (1) HK1209783A1 (de)
HU (1) HUE032238T2 (de)
IL (1) IL164048A0 (de)
MX (1) MXPA04009031A (de)
PL (1) PL372619A1 (de)
RU (1) RU2327479C2 (de)
SI (1) SI1490480T1 (de)
WO (1) WO2003078588A2 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04009031A (es) * 2002-03-15 2005-12-12 Incara Cell Technologies Inc Celulas madre hepaticas primitivas y proximales.
WO2007083504A1 (ja) * 2003-08-01 2007-07-26 Norimasa Nakamura スキャフォールドフリー自己組織性三次元人工組織（Ｓｃａｆｆｏｌｄ－ｆｒｅｅ Ｓｅｌｆ－Ｏｒｇａｎｉｚｅｄ ３Ｄ ｓｙｎｔｈｅｔｉｃ ｔｉｓｓｕｅ）
JP4522994B2 (ja) 2003-08-01 2010-08-11 憲正 中村 スキャフォールドフリー自己組織性三次元人工組織（Ｓｃａｆｆｏｌｄ−ｆｒｅｅＳｅｌｆ−Ｏｒｇａｎｉｚｅｄ３Ｄｓｙｎｔｈｅｔｉｃｔｉｓｓｕｅ）
WO2005108559A2 (en) * 2004-04-23 2005-11-17 Bioe, Inc. Multi-lineage progenitor cells
US7622108B2 (en) * 2004-04-23 2009-11-24 Bioe, Inc. Multi-lineage progenitor cells
WO2006126219A1 (en) * 2005-05-26 2006-11-30 Fresenius Medical Care Deutschland G.M.B.H. Liver progenitor cells
EP1954804A4 (de) 2005-11-16 2009-03-04 Univ North Carolina Extrazelluläre matrixkomponenten zur erweiterung oder differenzierung von hepatischen vorläufern
US20070148141A1 (en) * 2005-12-22 2007-06-28 Vesta Therapeutics Inc. Method of using hepatic progenitors in treating liver dysfunction
EP2019858B1 (de) * 2006-04-17 2012-06-13 BioE LLC Differenzierung von vorläuferzellen mit mehreren abstammungslinien in respiratorischen epithelzellen
EP2019859A4 (de) * 2006-04-25 2009-11-25 Univ Louisiana State Erwachsene stammzellen aus fettgewebe für leberregenerierung
HUE036729T2 (hu) * 2006-05-26 2018-07-30 Univ North Carolina Chapel Hill Máj stellát sejt prekurzorok és eljárások azok elõállítására
IN2010KN00157A (de) * 2007-06-15 2015-08-28 Univ North Carolina
EP2192908A4 (de) * 2007-07-25 2010-09-01 Bioe Inc Differenzierung von vorläuferzellen mehrerer abstammung gegenüber chondrozyten
WO2009134773A1 (en) * 2008-05-02 2009-11-05 Vesta Therapeutics, Inc. Hepatic progenitor cell and method of isolating same
EP2295537A4 (de) * 2008-05-14 2011-11-30 Public Univ Corp Yokohama City Menschliche leberstammzelle, verfahren zu ihrer herstellung, verfahren zur einleitung ihrer differenzierung und verfahren zu ihrer verwendung
US20090291494A1 (en) * 2008-05-21 2009-11-26 Bioe, Inc. Differentiation of Multi-Lineage Progenitor Cells to Pancreatic Cells
JP2011520470A (ja) * 2008-05-22 2011-07-21 ヴェスタ セラピューティクス，インコーポレーテッド 哺乳動物プロジェニター細胞をインスリン産生膵島細胞に分化させる方法
US20100227393A1 (en) * 2009-03-06 2010-09-09 Eric Lagasse Liver stem cells: isolation of hepatic progenitor cells from the human gall bladder
PH12012500845A1 (en) * 2009-10-30 2013-01-07 Sapienza Univ Di Roma Multipotent stem cells from the extrahepatic billary tree and methods of isolating same
WO2012067259A1 (ja) 2010-11-19 2012-05-24 株式会社オンチップ・バイオテクノロジーズ 高濃度夾雑細胞群から低濃度の特定細胞を検出する方法と検出した細胞を回収し解析する方法
SG195125A1 (en) * 2011-05-27 2013-12-30 Atrm Llc Bioartificial proximal tubule systems and methods of use
HUE030541T2 (en) * 2011-12-08 2017-05-29 Yeda Res & Dev Mammalian fetal lung cells and their therapeutic use
CN104508122A (zh) * 2012-06-20 2015-04-08 赛璐拉有限公司 用于处理细胞群体的材料和方法
JP6510162B2 (ja) * 2013-01-21 2019-05-08 テルモ株式会社 シート状細胞培養物の製造方法
US9533013B2 (en) * 2013-03-13 2017-01-03 University Of North Carolina At Chapel Hill Method of treating pancreatic and liver conditions by endoscopic-mediated (or laparoscopic-mediated) transplantation of stem cells into/onto bile duct walls of particular regions of the biliary tree
US10004767B2 (en) * 2013-09-19 2018-06-26 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for producing hepatocyte-like cells
CN111635883A (zh) 2013-12-16 2020-09-08 弗雷森纽斯医疗护理德国有限责任公司 胰岛样细胞结构及其制备方法
JP6595157B2 (ja) * 2014-03-04 2019-10-23 富士フイルム株式会社 細胞撮像制御装置および方法並びにプログラム
WO2016183231A1 (en) 2015-05-12 2016-11-17 Baker Group, LLP Method and system for a bioartificial organ
WO2016200340A1 (en) * 2015-06-12 2016-12-15 Agency For Science, Technology And Research Derivation of hepatic stem cells and mature liver cell types and uses thereof
US10668109B2 (en) 2015-06-18 2020-06-02 Yeda Research And Development Co. Ltd. Conditioning protocols and use of same for tissue regeneration
CN105483077A (zh) * 2015-12-24 2016-04-13 福州市传染病医院 一种提高肝细胞增殖活性的细胞培养方法
JP2019134682A (ja) * 2016-06-01 2019-08-15 国立研究開発法人医薬基盤・健康・栄養研究所 肝幹細胞様細胞の調製方法
US10767164B2 (en) 2017-03-30 2020-09-08 The Research Foundation For The State University Of New York Microenvironments for self-assembly of islet organoids from stem cells differentiation
BR112020015149A2 (pt) * 2018-01-26 2021-01-05 Polarityte, Inc. Materiais de automontagem coordenados por interface de complexos vivos (clicsam)
EP4293109A1 (de) 2022-06-14 2023-12-20 Upside Foods, Inc. Nicht-skelettartige muskelabgeleitete zellen als quelle für suspendierbare myogene zellen für kultivierte lebensmittel

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5665589A (en) * 1988-12-14 1997-09-09 The United States Of America As Represented By The Department Of Health And Human Services Human liver epithelial cell lines
JPH07501206A (ja) 1991-08-07 1995-02-09 イェシバ・ユニバーシティ 前駆肝細胞の増殖
JPH09505206A (ja) * 1993-11-19 1997-05-27 イェシバ・ユニバーシティ 肝芽細胞およびその単離方法
ZA951199B (en) * 1994-02-14 1996-08-14 Kirin Brewery Protein having tpo activity
US5843633A (en) * 1996-04-26 1998-12-01 Amcell Corporation Characterization of a human hematopoietic progenitor cell antigen
MXPA00010151A (es) * 1998-04-17 2002-08-06 Lexigen Pharm Corp Mejoramiento de las respuestas inmunes mediadas por proteina de fusion de anticuerpo-citocina mediante la soadministracion con inhibidores de prostaglandina.
US6129911A (en) 1998-07-10 2000-10-10 Rhode Island Hospital, A Lifespan Partner Liver stem cell
PE20001250A1 (es) * 1998-11-16 2000-11-21 Detroit Diesel Corp Metodo y sistema para el control de material devuelto
JP2000287680A (ja) * 1999-04-09 2000-10-17 Sentan Kagaku Gijutsu Incubation Center:Kk 未成熟肝細胞を成熟肝細胞へ分化させる方法
JP3553858B2 (ja) * 1999-08-25 2004-08-11 東洋紡績株式会社 血管網類似構造体を有する細胞培養用モジュール
JP2004510434A (ja) * 2000-10-03 2004-04-08 ユニバーシティ　オブ　ノース　カロライナ 肝前駆細胞のクローン増殖方法
MXPA04009031A (es) * 2002-03-15 2005-12-12 Incara Cell Technologies Inc Celulas madre hepaticas primitivas y proximales.

Also Published As

Publication number Publication date
PL372619A1 (en) 2005-07-25
AU2008202656B2 (en) 2011-03-17
WO2003078588A9 (en) 2003-12-11
EP3023491A1 (de) 2016-05-25
HK1209783A1 (en) 2016-04-08
JP2005520513A (ja) 2005-07-14
JP5463271B2 (ja) 2014-04-09
US8691523B2 (en) 2014-04-08
EP1490480A4 (de) 2006-06-14
WO2003078588A3 (en) 2004-04-01
WO2003078588A2 (en) 2003-09-25
US20070099297A1 (en) 2007-05-03
EP1490480B1 (de) 2016-02-03
CN1742082B (zh) 2015-01-21
JP2011087591A (ja) 2011-05-06
AU2008202656A8 (en) 2011-12-15
MXPA04009031A (es) 2005-12-12
US20170096641A1 (en) 2017-04-06
AU2008202656A1 (en) 2008-07-10
AU2008202656B8 (en) 2011-12-15
RU2327479C2 (ru) 2008-06-27
CY1118167T1 (el) 2017-06-28
US20040018621A1 (en) 2004-01-29
US7413897B2 (en) 2008-08-19
ES2569951T3 (es) 2016-05-13
RU2005125598A (ru) 2006-01-27
CA2479510A1 (en) 2003-09-25
KR20060010693A (ko) 2006-02-02
AU2003233399B2 (en) 2008-03-20
EP1490480A2 (de) 2004-12-29
DK1490480T3 (en) 2016-04-11
SI1490480T1 (sl) 2016-06-30
CN1742082A (zh) 2006-03-01
CN104630129A (zh) 2015-05-20
JP4723811B2 (ja) 2011-07-13
KR101119878B1 (ko) 2012-03-09
HUE032238T2 (en) 2017-09-28
US20140302601A1 (en) 2014-10-09
CA2479510C (en) 2019-10-29
AU2003233399A1 (en) 2003-09-29

Similar Documents

Publication Publication Date Title
IL164048A0 (en) Primitive and proximal hepatic stemcells
PT2702871T (pt) Biotecido de colagénio e sua utilização
EP1367060A4 (de) Glukopyranosyloxybenzylbenzolderivate und deren medizinische verwendung
EP1364957A4 (de) Glykopyranosyloxypyrazolderivate und deren medizinische verwendung
EP1364958A4 (de) Glykopyranosyloxypyrazolderivate und deren medizinische verwendung
AU2003228445A8 (en) Tissue composites and uses thereof
IL175858A0 (en) Extended use combination comprising estrogens and progestins
TWI316092B (en) Alloy and its use
IL163868A0 (en) Hermiasterlin derivatives and uses thereof
AU2001264258A1 (en) Nonwoven-fabric laminate and use thereof
AU151960S (en) Combination electrosurgical generator and cart
GB0114014D0 (en) Compostion and use
AU2002210916A1 (en) Endoscope attachment and endoscope
AU151959S (en) Surgical cart
GB0220214D0 (en) Compounds and their use
AU2003296369A8 (en) Imminoamines and preparation thereof
HUP0301993A3 (en) Sprayable browning composition and use thereof
AU7458201A (en) Laminate and use thereof
AU2001235363A1 (en) Mibefradil analogues and their use
AU2003205963A8 (en) Azaphenylalanine derivatives and their use as antithrombotic agents
GB0227906D0 (en) Compounds and their use
EP1367123A4 (de) Neurotonin und dessen verwendung
AU2001277519A1 (en) Bio-probes and use thereof
GB0230134D0 (en) Compounds and their use
EP1499338A4 (de) 7-hydroxy-16alpha-fluor-5-androsten-17-one und 7-hydroxy-16alpha-fluor-5-androstan-17-one und ihre derivate

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees